Approvals/CIMA-AEMPS/CABAZITAXEL AUROVIT 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION

Approved

STANDARD

CABAZITAXEL AUROVIT 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION

Eugia Pharma (Malta) Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 5662fa1f3c9294e1
Drug Cima Aemps Name: CABAZITAXEL AUROVIT 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number: 88361
Holder Company Name: Eugia Pharma (Malta) Limited
Marketing Company Name: Aurovitas Spain, S.A.U.
Authorization Date: 2022-12-09
Dosage Form: CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 20 MG
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Eugia Pharma (Malta) Limited

CABAZITAXEL

20 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Dec 9, 2022

Approval ID

5662fa1f3c9294e1

Type

Standard